Print

Eli Lilly and Company (LLY) Will Invest $350 Million In China Diabetes Cartridge Facility  
11/14/2013 1:59:37 PM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

November 14, 2013 -- Lilly announced it will spend $350 million in China to increase its production of insulin cartridges. The company emphasized that China is home to the world’s largest population of diabetics – which numbers almost 100 million now and is expected to grow as China’s population adopts western lifestyles. The China investment is part of a larger $1 billion building projects that Lilly has announced since the beginning of the year to increase diabetes drug capacity. More details....

Stock Symbol: (NYSE: LLY)

Help employers find you! Check out all the jobs and post your resume.

//-->